Complementary feeding represents a critical milestone in infant nutrition, where appropriate timing and informed decision-making are of great importance. M
Chronic nonbacterial osteomyelitis (CNO) is a rare autoinflammatory disease affecting the bone in which, diagnostic delays are common due to lack of physician awareness. The aim of this study was to evaluate the knowledge of orthopedic surgeons and pediatricians about CNO and to investigate the effect of professional experience on this process. This study was conducted between January-February 2025 using a 13-item online questionnaire comprising multiple-choice questions with clearly defined correct and incorrect answers. The questionnaire consisted of two main categories. The first category included questions regarding the clinicians' areas of specialization, professional experience, and training needs. The second category aimed to assess clinicians' knowledge levels about CNO. For each participant, the number and rate of correct and incorrect responses were calculated. The questionnaire was sent to a total of 551 clinicians and 244 of them (44.2%) (130 orthopedic surgeons, 114 pediatricians) completed the questionnaire. Of the 61 items, orthopedic surgeons had a median of 30 correct responses (26-35), while pediatricians had a median of 32 (28-36) (p = 0.023). The rate of giving the correct answers to the questions increased with the professional experience of the clinicians (p = 0.02). 116 (47.5%) clinicians stated that they didn't think to have sufficient knowledge about CNO and 212 (86.8%) clinicians stated that they'd like to participate in a training about CNO. This study demonstrates that both orthopedic surgeons and pediatricians still have significant knowledge gaps regarding CNO. Although the current level of awareness remains limited in both groups, they appear willing to acquire further knowledge. These findings highlight the need for focused educational programs to improve patient care.
21 May 2026 in Turkish Journal of Pediatric Disease
Objective: Organic acidemias (OAs) are metabolic disorders characterized by enzyme deficiencies that impair amino acid catabolism, leading to metabolic imbalances. Essential fatty acids (EFAs), particularly Omega-3 and Omega-6, are vital for cellular and neurological functions but are often affected by protein-restricted diets used in OA management. The aim of this study was to evaluate the plasma EFA levels in OA patients and explores their clinical relevance. Materials and Methods: A prospective, case-control design was adopted, including 26 OA patients (methylmalonic acidemia, propionic acidemia, isovaleric acidemia, maple syrup urine disease) and 22 healthy age- and gender-matched controls. Plasma EFA levels were quantified via gas chromatography-mass spectrometry. Cognitive and psychiatric evaluations were performed using standardized tests, including DSM-V-TR criteria, Wechsler Intelligence Scale for Children, and other psychometric tools. Statistical analyses assessed the relationships between EFA levels and clinical findings. Results: Organic acidemias patients exhibited significantly lower levels of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) + DHA, and Omega-3 compared to controls, with higher Omega-6/Omega-3 ratios. Despite these findings, no significant correlations emerged between EFA levels and cognitive or psychiatric outcomes. Conclusion: EFA deficiencies are prevalent among OA patients on protein-restricted diets, underscoring the potential need for targeted nutritional interventions. However, the absence of a direct association with clinical findings suggests multifactorial influences on disease outcomes. Future research should explore the longitudinal effects of EFA supplementation and its role in mitigating neurodevelopmental impairments in OA.
30 May 2022 in Turkish Journal of Pediatric Disease
Amaç: Bu çalışmanın amacı, referans bir çocuk hastanesinde belirgin olarak artmış eritrosit sedimantasyon hızı (ESR) olan pediatrik hastaların sıklığını, demografik ve klinik özelliklerini değerlendirmek ve klinisyenlerin aşırı yüksek ESR'yi ayırıcı tanıda kullanma becerilerini geliştirmektir. Gereç ve Yöntem: Retrospektif, kesitsel olarak planlanmış olan bu çalışmada ESR değeri ≥100 mm/saat olan pediyatrik hastalar değerlendirilmiştir. Hastalar tanılarına göre enfeksiyöz, enfeksiyöz olmayan inflamatuar hastalıklar (NIID), malignite, nefrolojik, diğer ve bilinmeyen olarak 6 ana gruba ayrıldı. Daha sonra hastaların spesifik alt tanıları belirlenerek, klinik ve laboratuvar verileri değerlendirildi. Bulgular: Yüksek ESR'si (≥20 mm/saat) olan toplam 3166 hasta içerisinde belirgin yüksek ESR'si olan 189 (%5.96) hasta çalışmaya dahil edildi. Belirgin yüksek ESR'nin en yaygın nedeni NIID (%35.9) iken, bunu enfeksiyonlar (%33.3), maligniteler (%19.0), nefrolojik (%2.6), diğer (%4.7) ve bilinmeyen (%4.2) olarak bulundu. En sık görülen spesifik alt tanı akut romatizmal ateş, Kawasaki hastalığı, lenfadenit ve lösemi idi. Yüksek ESR, yalnızca hemoglobin ve albümin seviyeleri ile negatif korelasyon gösterdi. Sonuç: Çalışmamız 3. Basamak, referans bir çocuk hastanesinde yapılmış literatürdeki en geniş seridir. Çocuklarda belirgin ESR yükselmesine neden olan en yaygın hastalıkların bilinmesi, klinisyenlere ayırıcı tanıda yardımcı olacaktır.
Vitamin ve Minerallerin Günlük Hayatımızdaki Yeri Murat ERSOY Vitamin ve Minerallerin İlave Olarak Alınması Gereken Durumlar Güldane Aylin İNAL Gebelikte Kullanılması Gereken Vitamin ve Mineraller Utkucan OKUDUCU Vitamin A Saliha BARUTÇU Adnan BARUTÇU Vitamin B1 (Tiamin) Burcu KÖŞECİ Vitamin B2 (Riboflavin) Nazmiye TÜZEL GÜNDÜZ Vitamin B3 (Niasin) Engin AYDIN Vitamin B5 (Pantotenik Asit) Nahide HAYKIR Vitamin B6 (Piridoksin) Merve YOLDAŞ ÇELİK Vitamin B7 (Biyotin) Fatma Derya BULUT İrem KEKEÇ Vitamin B9 (Folik Asit) Necla İPAR Vitamin B12 (Kobalaminler) Feza SARI ŞEN Vitamin C Hüseyin GÜMÜŞ Halil ASLAN Vitamin D Abdullah GÜNDÜZ Deniz KOR Vitamin E Sevinç GARİP Vitamin K Aysel Burcu İBİLİ Demir Cüneyt UĞUR Çinko Melis AKPINAR Kalsiyum Hilmi Onur KABUKÇU Magnezyum Merve KİŞİOĞLU Sodyum Hülya NALÇACIOĞLU Klor Gözde ATASEVER YILDIRIM Potasyum Mihriban İNÖZÜ Fosfor Ali Emre ÇETİNKOL İyot Mehmet Deniz ERHAN Selenyum Adnan BARUTÇU Krom Atilla GÜRAY Bakır Esra EREN Flor Enes Kaan KILIÇ Manganez Furkan KALAYCI Molibden Esra KARA Bor Fatma Derya BULUT Omega-3 Ümit ECE Omega - 6 Mehmet ALMACIOĞLU Koenzim Q10 Ezgi BURGAÇ Kolin-İnositol-PABA Zeliha HAYTOĞLU
16 September 2026 in Turkish Journal of Pediatric Disease
We sincerely thank the authors for their thoughtful comments and for their interest in our article entitled “Prevalence and Clinical Predictors of Sleep Disturbances in Children with Seasonal Allergic Rhinitis.” We appreciate their constructive observations, which provide an opportunity to further clarify the interpretation of our findings. The authors raise an important methodological point regarding the potential conceptual overlap between the Allergic Rhinitis and its Impact on Asthma (ARIA) severity classification and the Sleep Disturbance Scale for Children (SDSC). We agree that impaired sleep is one of the components considered when classifying allergic rhinitis as moderate-to-severe according to the ARIA guidelines, and therefore some degree of overlap between disease severity and sleep outcomes is theoretically possible. Regarding the specific question of how many children fulfilled the moderate-to-severe ARIA classification solely because of sleep impairment, this information was unfortunately not available, as we evaluated only the overall ARIA severity classification and did not record the individual criteria contributing to disease severity separately. We agree that evaluating disease severity after excluding the sleep-related criterion would represent a valuable methodological approach and could further clarify this relationship in future studies. The authors also appropriately emphasize that pediatric sleep health is influenced by multiple biological, behavioral, familial, environmental, and developmental factors. We fully agree with this broader perspective. Variables such as screen exposure, physical activity, bedtime routines, and sleep hygiene were not systematically collected, as they were beyond the predefined scope of our study, which primarily focused on the relationship between allergic disease characteristics and sleep disturbances. We acknowledge that these factors may influence sleep quality independently or interact with allergic symptoms, and their inclusion in future prospective studies would provide a more comprehensive understanding of sleep health in children with seasonal allergic rhinitis. Similarly, we appreciate the authors’ comments regarding the broad age range of our study population. We agree that sleep characteristics and their determinants may differ between school-aged children and adolescents owing to developmental and behavioral changes. Participants aged 6–16 years were included in the study because the assessment tool used has been validated for this age range. Furthermore, 78 of the 115 participants (67.8%) were aged 10 years or older, indicating that the study population predominantly consisted of older children and adolescents. Although age was recorded as a demographic variable, age-stratified analyses were not prespecified in our study, and the age groups were therefore not analyzed separately. We believe that future studies specifically designed to evaluate developmental differences across age groups would provide valuable additional insight into the relationship between allergic rhinitis and sleep disturbances. Once again, we thank the authors for their insightful comments and for highlighting important considerations regarding the interpretation of pediatric sleep research. We believe these observations complement our findings and further emphasize the importance of adopting a comprehensive approach when evaluating sleep health in children with seasonal allergic rhinitis.